| Fulminant pneumatosis intestinalis in a patient with diabetes mellitus and minimal change nephrotic syndrome. | |
| | |
MedLine Citation:
|
PMID: 17202732 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We report a case of pneumatosis intestinalis in a diabetic patient with minimal change nephrotic syndrome, receiving immunosuppressive drugs and an alpha-glucosidase inhibitor. The patient was a 72-year-old female, who suffered from right lower abdominal pain. Abdominal CT showed massive air in the intestinal wall, compatible with pneumatosis intestinalis. Her general condition rapidly deteriorated with systemic inflammatory response syndrome. The patient had received respiratory support for a week, along with antimicrobial therapy and continuous hemofiltration, and then recovered. Even though pneumatosis intestinalis is generally recognized as a mild disease, careful attention is necessary when it follows a serious condition. |
| | |
Authors:
|
Yoshitaka Maeda; Naoto Inaba; Makoto Aoyagi; Eiichiro Kanda; Tatsuo Shiigai |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2007-01-01 |
Journal Detail:
|
Title: Internal medicine (Tokyo, Japan) Volume: 46 ISSN: 1349-7235 ISO Abbreviation: Intern. Med. Publication Date: 2007 |
Date Detail:
|
Created Date: 2007-01-04 Completed Date: 2007-01-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9204241 Medline TA: Intern Med Country: Japan |
Other Details:
|
Languages: eng Pagination: 41-4 Citation Subset: IM |
Affiliation:
|
Nephrology Section, Department of Internal Medicine, Toride Kyodo General Hospital, Tokyo. yoshimaeda43@yahoo.co.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Diabetes Complications / complications*, drug therapy Enzyme Inhibitors / adverse effects, therapeutic use Female Hemofiltration Humans Immunosuppressive Agents / adverse effects, therapeutic use Nephrosis, Lipoid / complications*, drug therapy Pneumatosis Cystoides Intestinalis / diagnosis, etiology* Risk Factors alpha-Glucosidases / antagonists & inhibitors |
| Chemical | |
Reg. No./Substance:
|
0/Enzyme Inhibitors; 0/Immunosuppressive Agents; EC 3.2.1.20/alpha-Glucosidases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sibling cases of Addison's disease caused by DAX-1 gene mutations.
Next Document: Sleep stage determines the expression pattern of sleep apneas.